Mylotarg, fludarabine, cytarabine (ara-C), and cyclosporine (MFAC) regimen as post-remission therapy in acute myelogenous leukemia
- 1 December 2003
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 52 (6) , 449-452
- https://doi.org/10.1007/s00280-003-0671-3
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: